Creates IPN complement to control diabetes

Researchers of the National Polytechnic Institute (IPN) work on the development of a food supplement that contains wareke , with the purpose that it contributes to improve the quality of life of the people who suffer Diabetes mellitus type 2 , without this food replacing the medication used by patients with this disease.

The group of researchers of the Interdisciplinary Professional Unit of Biotechnology (UPIBI) of the IPN, headed by the doctor María Guadalupe Ramírez Sotelo , carries out an exhaustive scientific investigation of the medicinal plant Ibervillea sonorae, commonly known as wareke , due to the fact that to elaborate the nutritional complement they look for to study in depth the properties of the plant and to standardize the correct doses so that the treatment is the suitable one.

Ramirez Sotelo said that currently there are tablets and capsules made from the root of the market. wareke , but it is necessary to have a backing with scientific research so that both the manufacturing processes and the doses are appropriate: "The supplement we are working on will be safe and will have all the necessary tests so that its therapeutic effects benefit the health of people with diabetes ”.

The political researcher indicated that the interest to develop a product of this type arose because traditionally there are people that to control their levels of glucose in the blood they use the infusion of wareke , without knowing the exact dose they should use, which can have undesirable or counterproductive effects such as causing hypoglycemia (Abnormally low blood glucose concentration)

Ramírez Sotelo explained that in people with diabetes the natural mechanism of absorption of the glucose at a cellular level and reported that according to the research carried out so far, the research group has verified that in studies at the cellular level 75% of the transport of glucose in the neuronal type, called glial cells .


Video Medicine: Web Hooks and the Programmable World of Tomorrow (April 2024).